6Pfaller MA, Johnes RN, Messer SA, et al. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program[J]. Diagn Microbiol Infect Dis, 1998, 31(1):327-332.
7Price MF, LaRocco MT, Gentry LO, et al. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period[J].Antimicrob Agents Chemother,1994,38(6):1422-1427.
8Pfaller MA, Johnes RN, Messer SA, et al. National epidemiology of mycoses survey :a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species[J]. Diagn Microbiol Infect Dis,1998,31(1):289-296.
9Liebowitz LD, Ashbee HR, Evans EG, et al. A two year global evaluation of susceptibility of Candida species to fluconazole by disk diffusion[J]. Diagn Microbiol Infect Dis, 2001, 40: 27-33.
